现代肿瘤医学
現代腫瘤醫學
현대종류의학
JOURNAL OF MODERN ONCOLOGY
2015年
17期
2436-2439
,共4页
庞赛楠%张志培%李维妙%孙盈%王磊%闫小龙%赵洋%李小飞%周钢
龐賽楠%張誌培%李維妙%孫盈%王磊%閆小龍%趙洋%李小飛%週鋼
방새남%장지배%리유묘%손영%왕뢰%염소룡%조양%리소비%주강
非小细胞肺癌%EGFR突变%19缺失%免疫组化
非小細胞肺癌%EGFR突變%19缺失%免疫組化
비소세포폐암%EGFR돌변%19결실%면역조화
non-small cell lung cancer( NSCLC)%EGFR mutation%19 deletion%immunochemistry
目的:探讨EGFR 19缺失突变在非小细胞肺癌( NSCLC)组织中的表达及与临床病理特点的关系,为NSCLC TKI个体化靶向治疗提供临床依据。方法:收集第四军医大学唐都医院胸腔外科2010年9月至2013年11月手术切除经ARMS法检测为19-Del的NSCLC标本125例。免疫组化检测EGFR 19-Del表达,半定量分析其与临床病理特点的关系。结果:19-Del阳性着色呈棕黄色或深黄色颗粒样,主要定位在细胞膜上。鳞癌和腺癌相比,19-Del的表达强度无统计学差异( P=0.480)。19-Del在肺腺癌病理分级、TNM分期、原发肿瘤大小、淋巴结转移状态以及肿瘤位置间表达差异显著(P值均<0.05),而在鳞癌组间差异无统计学意义(P值均>0.05)。另外,19-Del表达在性别、年龄、吸烟史组中差异性不显著(P值均>0.05)。19-Del的阳性程度与ARMS法RT-PCR中Ct值之间有较强负相关性( P=0.000,rs =-0.662)。结论:19-Del表达强度与NSCLC的病理分级、TNM分期、淋巴结转移状态等相关,提示19-Del很可能具有促进肺癌发生发展的作用。免疫组化方法检测EGFR 19缺失突变结果与ARMS法一致性较好,方法可行。
目的:探討EGFR 19缺失突變在非小細胞肺癌( NSCLC)組織中的錶達及與臨床病理特點的關繫,為NSCLC TKI箇體化靶嚮治療提供臨床依據。方法:收集第四軍醫大學唐都醫院胸腔外科2010年9月至2013年11月手術切除經ARMS法檢測為19-Del的NSCLC標本125例。免疫組化檢測EGFR 19-Del錶達,半定量分析其與臨床病理特點的關繫。結果:19-Del暘性著色呈棕黃色或深黃色顆粒樣,主要定位在細胞膜上。鱗癌和腺癌相比,19-Del的錶達彊度無統計學差異( P=0.480)。19-Del在肺腺癌病理分級、TNM分期、原髮腫瘤大小、淋巴結轉移狀態以及腫瘤位置間錶達差異顯著(P值均<0.05),而在鱗癌組間差異無統計學意義(P值均>0.05)。另外,19-Del錶達在性彆、年齡、吸煙史組中差異性不顯著(P值均>0.05)。19-Del的暘性程度與ARMS法RT-PCR中Ct值之間有較彊負相關性( P=0.000,rs =-0.662)。結論:19-Del錶達彊度與NSCLC的病理分級、TNM分期、淋巴結轉移狀態等相關,提示19-Del很可能具有促進肺癌髮生髮展的作用。免疫組化方法檢測EGFR 19缺失突變結果與ARMS法一緻性較好,方法可行。
목적:탐토EGFR 19결실돌변재비소세포폐암( NSCLC)조직중적표체급여림상병리특점적관계,위NSCLC TKI개체화파향치료제공림상의거。방법:수집제사군의대학당도의원흉강외과2010년9월지2013년11월수술절제경ARMS법검측위19-Del적NSCLC표본125례。면역조화검측EGFR 19-Del표체,반정량분석기여림상병리특점적관계。결과:19-Del양성착색정종황색혹심황색과립양,주요정위재세포막상。린암화선암상비,19-Del적표체강도무통계학차이( P=0.480)。19-Del재폐선암병리분급、TNM분기、원발종류대소、림파결전이상태이급종류위치간표체차이현저(P치균<0.05),이재린암조간차이무통계학의의(P치균>0.05)。령외,19-Del표체재성별、년령、흡연사조중차이성불현저(P치균>0.05)。19-Del적양성정도여ARMS법RT-PCR중Ct치지간유교강부상관성( P=0.000,rs =-0.662)。결론:19-Del표체강도여NSCLC적병리분급、TNM분기、림파결전이상태등상관,제시19-Del흔가능구유촉진폐암발생발전적작용。면역조화방법검측EGFR 19결실돌변결과여ARMS법일치성교호,방법가행。
Objective:In order to provide clinical basis for the individual target-therapy of NSCLC TKI,the ex-pression of EGFR exon 19 deletion in NSCLC tissues and the correlation with clinicopathological features were investi-gated. Methods:NSCLC samples with EGFR exon 19 deletion were collected,which were selected by ARMS in Tang-du Hospital of Fourth Military Medical University from September 2010 to November 2013,and the expression of 19-Del was detected by immunochemistry in NSCLC,then the relevance of 19-Del with clinicopathological features was analyzed using semi-quantitatively. Results:The expression of EGFR with exon 19 deletion was mainly located in cell membrane and was stained to yellow or deep yellow. There was no significant differences of 19-Del expression between the squamous carcinoma group and the adenocarcinoma group(P=0. 480). There were significant differ-ences of 19-Del among the different pathological grades,TNM stages,the tumor size,lymph node metastasis status and tumor locationgroups in lung adenocarcinoma(P<0. 05),while there were no statistical differences about the features of TNM stage et al. in squamous carcinoma(P>0. 05). Furthermore,the difference for 19-Del expression in the gender,age and smoking history groups were not significant(P>0. 05). And the correlation between the posi-tive degree of 19-Del and Ct value in ARMS was strong negative(P=0. 000,rs = -0. 662). Conclusion:There were good correlations of 19 -Del with histological grades,TNM stages and lymph nodemetastasis status,prompting that the 19-Del mutation may affect tumorgenesis and progression. The detecting result of 19-Del is in good consis-tency with the ARMS which means that the immunochemistrymethod is feasible.